Citation: | LIU Jiao, FANG Ru-meng, WANG Tao, LI Zhi-jun. Analysis of clinical features and prognosis of antineutrophil cytoplasmic antibody with infection[J]. Chinese Journal of General Practice, 2021, 19(9): 1480-1483. doi: 10.16766/j.cnki.issn.1674-4152.002091 |
[1] |
PAGNOUX C. Updates in ANCA-associated vasculitis[J]. Eur J Rheumatol, 2016, 3(3): 122-133. doi: 10.5152/eurjrheum.2015.0043
|
[2] |
SCOTT J, HARTNETT J, MOCKLER D, et al. Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review[J]. Autoimmun Rev, 2020, 19(11): 102660. doi: 10.1016/j.autrev.2020.102660
|
[3] |
ADDY C, DORAN G, JONES A L, et al. Microscopic polyangiitis secondary to mycobacterium abscessus in a patient with bronchiectasis: A case report[J]. BMC Pulm Med, 2018, 18(1): 170. doi: 10.1186/s12890-018-0732-3
|
[4] |
YANG L, XIE H L, LIU Z Z, et al. Risk factors for infectious complications of ANCA-associated vasculitis: A cohort study[J]. BMC Nephrol, 2018, 19(1): 138. doi: 10.1186/s12882-018-0933-2
|
[5] |
MCGREGOR J G, NEGRETE-LOPEZ R, POULTON C J, et al. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function[J]. Nephrol Dial Transpl, 2015, 30(1): i171-i181. http://smartsearch.nstl.gov.cn/paper_detail.html?id=d46a0b285ac021c6a50021dc380a3e1b
|
[6] |
HARISÁ H, POLNER K, ARÁNYI J, et al. Simple, Readily available clinical indices predict early and late mortality among patients with ANCA-associated vasculitis[J]. BMC Nephrol, 2017, 18(1): 76. doi: 10.1186/s12882-017-0491-z
|
[7] |
THOMAS K, VASSILOPOULOS D. Infections and vasculitis[J]. Curr Opin Rheumatol, 2017, 29(1): 17-23. doi: 10.1097/BOR.0000000000000348
|
[8] |
SCHIEFERMUELLER J, ALAOUR B, CALVER A, et al. Lesson of the month 1: Beware the atypical presentation: Eosinophilic granulomatosis with polyangiitis presenting as acute coronary syndrome[J]. Clin Med, 2017, 17(2): 180-182. doi: 10.7861/clinmedicine.17-2-180
|
[9] |
ZHANG R, WANG S Y, ZHANG M, et al. Hyponatremia in patients with chronic kidney disease[J]. Hemodial Int, 2017, 21(1): 3-10. doi: 10.1111/hdi.12447
|
[10] |
XU P C, TONG Z Y, CHEN T, et al. Hypoalbuminaemia in antineutrophil cytoplasmic antibody-associated vasculitis: Incidence and significance[J]. Clin Exp Rheumatol, 2018, 36(4): 603-611. http://www.ncbi.nlm.nih.gov/pubmed/29352844
|
[11] |
袁瑞丽, 杨云娇, 李菁. 抗中性粒细胞胞浆抗体相关性血管炎感染患者淋巴细胞及CD4+ T细胞减少与死亡的相关性[J]. 中华临床免疫和变态反应杂志, 2020, 14(2): 49-54. https://www.cnki.com.cn/Article/CJFDTOTAL-OZHL202002007.htm
|
[12] |
JENNETTE J C, NACHMAN P H. ANCA glomerulonephritis and vasculitis[J]. Clin J Am Soc Nephrol, 2017, 12(10): 1680-1691. doi: 10.2215/CJN.02500317
|
[13] |
SHI L. Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes[J]. Rheumatol Int, 2013, 37(11): 1779-1788. http://www.onacademic.com/detail/journal_1000040080547210_7043.html
|
[14] |
JONES R B, HIEMSTRA T F, BALLARIN J, et al. Mycophenolate mofetil versus cyclophosphamide for remission induction in anca-associated vasculitis: A randomised, non-inferiority trial[J]. Ann Rheum Dis, 2019, 78(3): 399-405. doi: 10.1136/annrheumdis-2018-214245
|
[15] |
MARTÍNEZ-MARTÍNEZ M U, OOSTDAM H V, ABUD-MENDOZA C. Diffuse alveolar hemorrhage in autoimmune diseases[J]. Curr Rheumatol Rep, 2017, 19(5): 27. doi: 10.1007/s11926-017-0651-y
|